Join us this week (December 10th-13th) at SABCS 2024, Booth 1343 to learn more about the only guideline-recognized test to predict the likelihood of extended endocrine therapy benefit for HR+, early-stage breast cancer. See you there! #breastcancer #breastcancerindex #SABCS24 #extendedendocrinetherapy Hologic, Inc.
Breast Cancer Index’s Post
More Relevant Posts
-
Learn about all the misconceptions regarding extended endocrine therapy to treat HR+, early -stage breast cancer. And let’s not have women suffer with unnecessary side effects. Find out more with the link below:
There are several misconceptions regarding extended endocrine therapy to treat HR+, early-stage breast cancer. Learn the data. Find out more about the Breast Cancer Index test: https://bit.ly/3BC0U1i Hologic, Inc. #BreastCancerAwarenessMonth #Hologic #BustTheMyth #breastcancerindex
-
-
There are several misconceptions regarding extended endocrine therapy to treat HR+, early-stage breast cancer. Learn the data. Find out more about the Breast Cancer Index test: https://bit.ly/3BC0U1i Hologic, Inc. #BreastCancerAwarenessMonth #Hologic #BustTheMyth #breastcancerindex
-
-
Breast self-exam, or regularly examining your breasts on your own, can be an important way to find breast cancer early, when it’s more likely to be treated successfully. Learn more about the self-exam here - https://ow.ly/mqew50TfOnR #BreastCancer #Screening #Exam #USALongevityCenters #CTScan #EarlyDetection
-
-
There are several misconceptions regarding extended endocrine therapy to treat HR+, early-stage breast cancer. Learn the data. Find out more about the Breast Cancer Index test: https://bit.ly/3BC0U1i Hologic, Inc. #BreastCancerAwarenessMonth #Hologic #BustTheMyth #breastcancerindex
-
-
There are several misconceptions regarding extended endocrine therapy to treat HR+, early-stage breast cancer. Learn the data. Find out more about the Breast Cancer Index test: https://bit.ly/3BC0U1i Hologic, Inc. #BreastCancerAwarenessMonth #Hologic #BustTheMyth #breastcancerindex
-
-
🎗️ This Pancreatic Cancer Awareness Month, we're spotlighting key research: Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia (IPMN): Findings from the multicentre ADENO-IPMN study 📖 Read the full study here: https://buff.ly/4eC2I8l #PancreaticCancerAwareness #CancerResearch #PancreaticCancer #IPMN
-
-
🏆 Positive Role Model Awardee| Promoting Holistic Health & Gender Equality 🩺 Nurse &Holistic Coach |Author| 💫 Energy Healer & Biohacker 🤝 Volunteer Wellness#Holistichealing#Therapist
Day 5 By understanding the different types of prostate cancer, we can shed light on the unique aspects of each subtype and discuss their implications for diagnosis, treatment, and prognosis. Join us as we dive into the various types of prostate cancer and their distinct features. https://lnkd.in/dfJzAnFb
-
-
Explore strategies with our On-Demand Video featuring breast cancer experts | Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes | 0.5-hour CME/CE | #MedEd #cme #HR+breastcancer | https://bit.ly/495OtG3
-
-
There are several misconceptions regarding extended endocrine therapy to treat HR+, early-stage breast cancer. Learn the data. Find out more about the Breast Cancer Index test: https://bit.ly/3BC0U1i Hologic, Inc. #BreastCancerAwarenessMonth #Hologic #BustTheMyth #breastcancerindex
-
-
Lilly's Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as Monotherapy and in Combination with Verzenio® (abemaciclib) in Patients with ER+, HER2- Advanced Breast Cancer http://ow.ly/PUxt105RmOj
Marketing, Strategic Marketing, Communications Leadership | BOD | Pharmaceutical | BioTech | Diagnostic | Medical Device | Ex-GE | US Navy Veteran | Caregiver
3wVery nice evolution of the messaging. Congratulations! Breast Cancer Index